Cargando…
Spider venom administration impairs glioblastoma growth and modulates immune response in a non-clinical model
Molecules from animal venoms are promising candidates for the development of new drugs. Previous in vitro studies have shown that the venom of the spider Phoneutria nigriventer (PnV) is a potential source of antineoplastic components with activity in glioblastoma (GB) cell lines. In the present work...
Autores principales: | Bonfanti, Amanda Pires, Barreto, Natália, Munhoz, Jaqueline, Caballero, Marcus, Cordeiro, Gabriel, Rocha-e-Silva, Thomaz, Sutti, Rafael, Moura, Fernanda, Brunetto, Sérgio, Ramos, Celso Dario, Thomé, Rodolfo, Verinaud, Liana, Rapôso, Catarina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125223/ https://www.ncbi.nlm.nih.gov/pubmed/32246025 http://dx.doi.org/10.1038/s41598-020-62620-9 |
Ejemplares similares
-
Isolated Components From Spider Venom Targeting Human Glioblastoma Cells and Its Potential Combined Therapy With Rapamycin
por: Caballero, Marcus, et al.
Publicado: (2022) -
Isolated Peptide from Spider Venom Modulates Dendritic Cells In Vitro: A Possible Application in Oncoimmunotherapy for Glioblastoma
por: de Mato, Felipe Cezar, et al.
Publicado: (2023) -
Spider venom components decrease glioblastoma cell migration and invasion through RhoA-ROCK and Na(+)/K(+)-ATPase β2: potential molecular entities to treat invasive brain cancer
por: Barreto, Natália, et al.
Publicado: (2020) -
Purification and characterization of a hyaluronidase from venom of the spider Vitalius dubius (Araneae, Theraphosidae)
por: Sutti, Rafael, et al.
Publicado: (2014) -
Scorpion and spider venoms in cancer treatment: state of the art, challenges, and perspectives
por: Rapôso, Catarina
Publicado: (2017)